Compare Ginkgo Bioworks Holdings Inc (DNA) vs Virgin Galactic Holdings, Inc. (SPCE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Virgin Galactic Holdings, Inc. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Virgin Galactic Holdings, Inc. trades at $3.31 (market cap $498.02M). The key difference: Ginkgo Bioworks Holdings Inc and Virgin Galactic Holdings, Inc. are close in size by market cap. Which is the better fit depends on your goals.
| DNA | SPCE | |
|---|---|---|
Market Cap | $505.73M | $498.02M |
Sector | Health | Industrials |
52-Week High | $16.14 | $7.52 |
52-Week Low | $5.48 | $2.17 |
Enterprise Value | $607.68M | $597.87M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Virgin Galactic Holdings, Inc.
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →
